Early haemodynamically significant patent ductus arteriosus does not predict future persistence in extremely preterm infants
- PMID: 30748032
- DOI: 10.1111/apa.14752
Early haemodynamically significant patent ductus arteriosus does not predict future persistence in extremely preterm infants
Abstract
Aim: We assessed whether early haemodynamically significant patent ductus arteriosus (hsPDA) predicted persistent patent ductus arteriosus (PDA) in extremely preterm infants.
Methods: This prospective observational study of 60 infants born at 22-27 weeks of gestational age (GA) without any major congenital anomalies or heart defects was conducted at Uppsala University Children's Hospital from November 2012 to May 2015. Respiratory and systemic circulatory parameters were continuously recorded, and echocardiographic examinations performed daily during the first three days of life. Pharmacological treatment was initiated if hsPDA was found on days two to seven. Persistent PDA was diagnosed if hsPDA remained after pharmacological treatment or pharmacological treatment was contraindicated.
Results: The infants (56% male) had a median GA of 25 + 2 weeks and 50% received pharmacological treatment. PDA was persistent in 30% and ultimately closed or insignificant in 70%. hsPDA on days two to seven was not associated with future persistent PDA (p = 1.000). Mechanical ventilation (p = 0.025), high mean airway pressure (p = 0.020) and low ductal maximal flow velocity (Vmax ) (p = 0.024) on day two were associated with future persistent PDA.
Conclusion: Early hsPDA did not predict persistent PDA, but the early need for assisted ventilation and low ductal Vmax were associated with future persistent PDA in these extremely preterm infants.
Keywords: Ductal flow velocity; Echocardiography; Extremely preterm infant; Haemodynamical significance; Patent ductus arteriosus.
©2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Similar articles
-
Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: Should we pay more attention?Early Hum Dev. 2019 Aug;135:16-22. doi: 10.1016/j.earlhumdev.2019.06.002. Epub 2019 Jun 15. Early Hum Dev. 2019. PMID: 31212222
-
[Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants].Zhonghua Er Ke Za Zhi. 2015 Mar;53(3):187-93. Zhonghua Er Ke Za Zhi. 2015. PMID: 26165015 Chinese.
-
Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.BMC Pediatr. 2019 Jun 5;19(1):179. doi: 10.1186/s12887-019-1560-1. BMC Pediatr. 2019. PMID: 31167645 Free PMC article.
-
[Transcatheter occlusion of patent ductus arteriosus in a preterm infant and review of literatures].Zhonghua Er Ke Za Zhi. 2016 Jan;54(1):43-6. doi: 10.3760/cma.j.issn.0578-1310.2016.01.010. Zhonghua Er Ke Za Zhi. 2016. PMID: 26791923 Review. Chinese.
-
Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.Pediatr Neonatol. 2020 Apr;61(2):133-141. doi: 10.1016/j.pedneo.2019.10.002. Epub 2019 Oct 29. Pediatr Neonatol. 2020. PMID: 31740267 Review.
Cited by
-
A Matched Case Control Study of Surgically and Non-surgically Treated Patent Ductus Arteriosus in Extremely Pre-term Infants.Front Pediatr. 2021 Mar 18;9:648372. doi: 10.3389/fped.2021.648372. eCollection 2021. Front Pediatr. 2021. PMID: 33816408 Free PMC article.
-
Increasing the dose of ibuprofen with postnatal age to close a hemodynamically significant patent ductus arteriosus in very preterm infants.Eur J Pediatr. 2023 Aug;182(8):3527-3535. doi: 10.1007/s00431-023-04986-2. Epub 2023 May 19. Eur J Pediatr. 2023. PMID: 37204599
-
An Update on Patent Ductus Arteriosus and What is Coming Next.Turk Arch Pediatr. 2022 Mar;57(2):118-131. doi: 10.5152/TurkArchPediatr.2022.21361. Turk Arch Pediatr. 2022. PMID: 35383006 Free PMC article.
-
Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.J Pers Med. 2022 Jul 14;12(7):1143. doi: 10.3390/jpm12071143. J Pers Med. 2022. PMID: 35887640 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- Center for Clinical Research Dalarna/International
- Samariten Foundation for Paediatric Research/International
- Födelsefonden/Perinatalmedicinska Forskningsfonden/International
- Royal Society of Arts and Sciences of Uppsala/International
- Crown Princess Lovisa's Foundation for Children's Health Care/International
LinkOut - more resources
Full Text Sources